Brussels Statement document

Piccart, Martine; Cataliotti, Luigi; Buchanan, Mary; Freilich, G.; Jassem, Jacek

doi:10.1016/s0959-8049(01)00134-4

Cited by 15 publications

(7 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This remains consistent in further updates of the reports issued by the UK National Institute of Health and Clinical Excellence (NICE) 11,12 and the European Society of Mastology (EUSOMA). The "Brussels Statement" in 2001 emphasised the need for breast cancer diagnosis and care to be carried out in accredited breast units that practice according to set guidelines 14 . This has consistently been re-iterated in further updates of these statements 15,16 and is increasingly adopted in various countries throughout Europe 6,17 .…”

Section: 1mentioning

confidence: 99%

Optimising the care of primary breast cancer in older women—potential for a dedicated service

Tang

Morgan

Winterbottom

et al. 2010

Journal of Geriatric Oncology

View full text Add to dashboard Cite

Section: 1mentioning

confidence: 99%

Optimising the care of primary breast cancer in older women—potential for a dedicated service

Tang

Morgan

Winterbottom

et al. 2010

Journal of Geriatric Oncology

View full text Add to dashboard Cite

“…49 Bundan ötürü Avrupa Bir-li¤i (AB)'nin kendi üye ülkeleri için yay›mlad›¤› tavsiye karar›nda meme kanseri için tarama bafllang›ç yafl› 50'dir. 50 Yine yap›lan çal›flmalarda bilateral çift yönlü mamografinin tek bafl›na yeterli bir yöntem oldu¤u gösterilmifltir. 51 Taraman›n bitifl yafl› için ise ço¤u çal›flmada 69 yafl s›n›r olarak belirtilmifltir.…”

Section: Tarama Prensipleri Ve Yöntemleriunclassified

“…49 AB'nin tavsiye karar›na göre; meme kanseri taramas› için mamografi 50 -69 yafl aras›nda düzenli olarak 2 y›lda bir yap›lmal›d›r. 50 Bu tavsiye karar› 2004 y›l›nda T.C. Sa¤l›k Bakanl›¤› Kanserle Savafl Daire Baflkanl›-¤› taraf›ndan da benimsenmifltir.…”

Section: Tarama Prensipleri Ve Yöntemleriunclassified

Approach to common breast diseases: risk evaluation and screening strategies for breast cancer

Güllüoğlu¹

2008

Turk Aile Hek Derg

View full text Add to dashboard Cite

Meme kanseri insidans› ve bu kansere ba¤l› ölüm oranlar› son on y›lda düflmüfltür. Ölüm oran›n›n azalmas›n›n nedenleri aras›nda meme kanserini daha erken evrede tan›yabilmek için yap›lan mamografik taraman›n etkinli¤i gösterilmektedir. Taraman›n meme kanserine ba¤l› ölüm oran›n› %25-30 oran›nda azaltt›¤› saptan-m›flt›r. Ancak ölüm oran›n›n azalmas›nda bu kanser hakk›ndaki fark›ndal›¤›n artmas› da etkili olmaktad›r. Ölüm oran›n›n azalmas›-n›n ötesinde son befl y›ld›r meme kanseri insidans›nda da belirgin bir düflüfl kay›t edilmektedir. Bu düflüfl daha çok postmenapozal kad›nlarda göze çarpmaktad›r. Bu durum postmenapozal kad›nla-r›n hormon replasman tedavisini eskisi kadar yayg›n olarak kullan-mamas›na ba¤lanmaktad›r. Bu geliflmeler kad›nlar›n meme kanseri için varolan risklerinin saptanmas› ve mümkün ise bu risk faktörlerini yaflamlar›ndan uzaklaflt›rmalar› konusunu gündeme getirmektedir. Bugün dünyada meme kanseri insidans›n›n yüksek oldu-¤u ülkelerde "risk analizi ve dan›flmanl›¤›" rutin sa¤l›k hizmeti içerisinde yerini almaktad›r. Bu ünitelerde kad›nlar›n rasyonel risk ölçümleri yap›lmakta ve risk düzeylerine göre tavsiyelerde bulunul-maktad›r. Etkin risk azalt›c› yöntemler aras›nda kemoprevensiyon ve profilaktik ameliyatlar yer almaktad›r. Bu derlemede sa¤l›kl› ka-d›nlar› meme kanseri riski aç›s›ndan de¤erlendirilerek, kimlerin risk analizi ve dan›flmanl›¤›na ihtiyac› oldu¤unu ay›rt etmesine yard›m-c› olacak bilgiler verilmeye çal›fl›lacakt›r. Ayr›ca ortalama riske sahip kad›nlara uygulanmas› tavsiye olunan ulusal tarama standart-lar›m›z aktar›lacakt›r.

show abstract

“…The guidelines have been generally well received and have been influential in the introduction of the multidisciplinary approach in several countries. The Brussels Statement [3], following the second EBCC drew again attention to these guidelines and demanded that processes of accreditation of breast units be implemented and expanded. The importance of the establishment of multidisciplinary breast units was again stressed in the Hamburg Statement [4] which followed the fourth EBCC.…”

Section: European Guidelines: Requirements Of a Specialist Breast Unitmentioning

confidence: 99%

Expanding the Breast Unit Accreditation Process to Ensure Standardization of Best Care for All Women Across Europe

Gatzemeier

2006

Breast Care

View full text Add to dashboard Cite

Breast cancer is the most common cancer and the most frequent cause of cancer death in women throughout Europe. However, mortality from breast cancer is decreasing as a result of concerted action by all parties involved. It is now widely accepted that multidisciplinary teams form the basis for best practice in the management of breast cancer. Across Europe, women should have equity of access and the choice to select appropriate facilities for diagnosis and treatment and be sure they are receiving gold standard. European guidelines set up by the European Society of Mastology (EUSOMA) and the European Organization for the Research and Treatment of Cancer Breast Cancer Cooperative Group (EORTC-BCCG) to define the gold standard - entitled ‘Requirements of a Breast Unit’ - have been generally well received and have been influential in the introduction of the multidisciplinary approach in several countries. EUSOMA implemented a European accreditation process in order give guidance to patients and referring doctors to recognize which units meet the requirements and standards of best care.

show abstract

Brussels Statement document

Cited by 15 publications

References 4 publications

Optimising the care of primary breast cancer in older women—potential for a dedicated service

Optimising the care of primary breast cancer in older women—potential for a dedicated service

Approach to common breast diseases: risk evaluation and screening strategies for breast cancer

Expanding the Breast Unit Accreditation Process to Ensure Standardization of Best Care for All Women Across Europe

Contact Info

Product

Resources

About